TRPC6 inhibitor (BI 764198) to reduce risk and severity of ARDS due to COVID-19: a phase II randomised controlled trial

  1. Ware, L.B.
  2. Soleymanlou, N.
  3. McAuley, D.F.
  4. Estrada, V.
  5. Diaz, G.A.
  6. Lacamera, P.
  7. Kaste, R.
  8. Choi, W.
  9. Gupta, A.
  10. Welte, T.
Journal:
Thorax

ISSN: 1468-3296 0040-6376

Year of publication: 2023

Volume: 78

Issue: 8

Pages: 816-824

Type: Article

DOI: 10.1136/THORAX-2022-219668 GOOGLE SCHOLAR lock_openOpen access editor